Roche (Romania)
In research, Roche (Romania) stands highest in Medicine (#17,962 of 17,978 worldwide) and Health Sciences (#20,452 of 20,462 worldwide), over all time.
- World rank, all time
- #42,824 of 42,892
- Rank in Romania
- #175 of 176
- Research works
- 160 ▼ 63% vs 2013–17
- Citations
- 98 0.6 per fractional work
- Top-10% rate
- 13.3% record average 16.5%
- Open access
- 92% world 28%
What is Roche (Romania) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #17,962 of 17,978 | 0.3% | 130 | |
| Health SciencesDomain | #20,452 of 20,462 | 0.6% | 132 |
Each strip is that field’s whole ranked pool, with the notch where Roche (Romania) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemical Engineering, 19.1×. Every wedge is a field page.
Which keywords describe research at Roche (Romania)?
By fractional works in all years, weighted toward what it does more of than the world: Diagnosis, Immunotherapy, Epidemiology, Treatment, Genetic Mutations, Management, Magnetic Resonance Imaging and Clinical Practice Guidelines.
- Rituximab
- Radiomics
- Pancreatic Cancer
- Precision Medicine
- PET Imaging
- Parallel Imaging
- Clinical Management
- Feature Extraction
- Prenatal Diagnosis
- NASH
- Endovascular Treatment
- Neoadjuvant Therapy
- Perfusion Imaging
- Radiosurgery
- Surgical Management
- Hepatocellular Carcinoma
- Clinical Practice Guidelines
- Management
- Immunotherapy
- Treatment
- Epidemiology
- Diagnosis
- Genetic Mutations
- Magnetic Resonance Imaging
- Chemotherapy
- Radiotherapy
- Prognostic Factors
- Risk Factors
- Metabolic Syndrome
- Complications
- NAFLD
- Neuroimaging
- Classification
- Medical Imaging
- Molecular Classification
- Spectroscopy
- Liver Transplantation
- Molecular Profiling
- Quantitative Analysis
- Surgical Complications
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology18▲ 2.9×30 topics
- Treatment12▲ 6.0×18 topics
- Diagnosis12▲ 7.5×18 topics
- Immunotherapy12▲ 11×9 topics
- Genetic Mutations9▲ 11×9 topics
- Management9▲ 7.2×13 topics
- Magnetic Resonance Imaging8▲ 14×5 topics
- Clinical Practice Guidelines8▲ 8.5×8 topics
- Chemotherapy7▲ 6.3×10 topics
- Hepatocellular Carcinoma7▲ 20×3 topics
- Radiotherapy7▲ 11×7 topics
- Surgical Management7▲ 9.2×8 topics
- Prognostic Factors7▲ 9.0×8 topics
- Radiosurgery6▲ 44×3 topics
- Risk Factors6▲ 3.8×9 topics
- Perfusion Imaging6▲ 34×2 topics
- Metabolic Syndrome5▲ 3.7×4 topics
- Neoadjuvant Therapy5▲ 14×4 topics
- Complications5▲ 5.7×7 topics
- Endovascular Treatment4▲ 43×2 topics
- NAFLD4▲ 24×1 topic
- NASH4▲ 24×1 topic
- Neuroimaging4▲ 8.8×5 topics
- Prenatal Diagnosis4▲ 14×4 topics
- Classification4▲ 6.8×3 topics
- Feature Extraction4▲ 8.6×2 topics
- Medical Imaging4▲ 8.8×2 topics
- Clinical Management4▲ 11×3 topics
- Molecular Classification4▲ 15×4 topics
- Parallel Imaging4▲ 31×1 topic
- Spectroscopy4▲ 6.8×1 topic
- PET Imaging3▲ 9.8×2 topics
- Liver Transplantation3▲ 14×3 topics
- Precision Medicine3▲ 6.7×3 topics
- Molecular Profiling3▲ 17×2 topics
- Pancreatic Cancer3▲ 17×1 topic
- Quantitative Analysis3▲ 12×1 topic
- Radiomics3▲ 31×1 topic
- Surgical Complications3▲ 27×1 topic
- Rituximab3▲ 12×2 topics
Which research topics does Roche (Romania) publish most on?
By volume in 2022–2025: Innovation Policy and R&D, Pharmaceutical Economics and Policy, Clinical Laboratory Practices and Quality Control and Mobile Health and mHealth Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Innovation Policy and R&D Economics and Econometrics 0 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 3 Clinical Laboratory Practices and Quality Control Physiology 0 works
- 4 Mobile Health and mHealth Applications General Health Professions 0 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 6 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 7 Chemical Safety and Risk Management Chemical Health and Safety 0 works
- 8 Molecular Biology Techniques and Applications Molecular Biology 0 works
- 9 Nutritional Studies and Diet Public Health, Environmental and Occupational Health 0 works
- 10 Regional Development and Policy Political Science and International Relations 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Roche (Romania)'s research output changed?
Output in 2018–2022 was 63% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bucharest
- Universitatea Națională de Știință și Tehnologie Politehnica București
- University of Bucharest
- Bucharest University of Economic Studies
- Romanian Academy
- Carol Davila University of Medicine and Pharmacy
- Clinical Emergency Hospital Bucharest
- Academia Oamenilor de Știință din România
- University of Agronomic Sciences and Veterinary Medicine of Bucharest
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.